Chemical Formula: C22H35NO2

Chemical Formula C22H35NO2

Found 24 metabolite its formula value is C22H35NO2

Himbacine

(+)-Himbacine

C22H35NO2 (345.266765)


A piperidine alkaloid that is decahydronaphtho[2,3-c]furan-1(3H)-one substituted by a methyl group at position 3 and a 2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl group at position 4. It has been isolated from the bark of Australian magnolias. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics relative retention time with respect to 9-anthracene Carboxylic Acid is 0.814 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.809

   

Eicosapentaenoyl Ethanolamide

(5Z,8Z,11Z,14Z,17Z)-N-(2-hydroxyethyl)icosa-5,8,11,14,17-pentaenamide

C22H35NO2 (345.266765)


Eicosapentaenoyl Ethanolamide (EPEA) is an endogenous fatty acid amide. EPEA is metabolized by fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA), the latter of which has more specificity toward PEA over other fatty acid amides. DHEA and eicosapentaenoyl ethanolamide (EPEA) bind to the CB1 receptor in rat brains.23 DHA levels in the mouse brain have been shown to inversely affect the levels of 2AG. Eicosapentaenoyl Ethanolamide (EPEA) is an endogenous fatty acid amide.

   

Himbacine

4-[2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3H-naphtho[2,3-c]furan-1-one

C22H35NO2 (345.266765)


   

1-Piperidinepropanol, alpha-cyclohexyl-4-(3-hydroxyphenyl)-3,4-dimethyl-

1-(3-Hydroxy-3-cyclohexylpropyl)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidine

C22H35NO2 (345.266765)


   

N-(2-Hydroxyethyl)icosa-2,4,6,8,10-pentaenamide

N-(2-Hydroxyethyl)icosa-2,4,6,8,10-pentaenimidate

C22H35NO2 (345.266765)


   

Dihydroatisine

F-Dihydroatisine

C22H35NO2 (345.266765)


   
   
   
   
   
   
   

Anandamide (20:5, n-3)

N-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-ethanolamine

C22H35NO2 (345.266765)


   

NAE 20:5

N-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-ethanolamine

C22H35NO2 (345.266765)


   
   

dehydroabietylamine acetate

dehydroabietylamine acetate

C22H35NO2 (345.266765)


   

7-Ethano-1H-isoindole-1, 3(2H)-dion, 2-(2-ethylhexyl)-3a,4,7,7a-tetrahydro-4-methyl-7-(1-methylethy4

7-Ethano-1H-isoindole-1, 3(2H)-dion, 2-(2-ethylhexyl)-3a,4,7,7a-tetrahydro-4-methyl-7-(1-methylethy4

C22H35NO2 (345.266765)


   

N-eicosapentaenoylethanolamine

N-eicosapentaenoylethanolamine

C22H35NO2 (345.266765)


   

(+)-Himbacine

(+)-Himbacine

C22H35NO2 (345.266765)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics

   

(5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine

(5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine

C22H35NO2 (345.266765)


An N-acylethanolamine 20:5 that is the ethanolamide of (5Z,8Z,11Z,14Z17Z)-eicosapentaenoic acid.

   

Eicosapentenoyl-EA

Eicosapentenoyl-EA

C22H35NO2 (345.266765)


   

LY255582

LY255582

C22H35NO2 (345.266765)


LY255582 is a pan-opioid antagonist and has high affinity for mu, delta, and kappa receptors (Ki: 0.4 nM, 5.2, 2.0 nM respectively). LY255582 can decrease food intake and body weight. LY255582 can be used for the research of obesity[1][2][3][4].

   

3-{14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl}propanoic acid

3-{14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl}propanoic acid

C22H35NO2 (345.266765)


   

methyl 3-[(1s,2s,3r,7s,10r,12r,13s)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

methyl 3-[(1s,2s,3r,7s,10r,12r,13s)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

C22H35NO2 (345.266765)